Previous 10 | Next 10 |
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) today announced that the stockholders of each of BridgeBio and Eidos voted to approve ...
Merger activity decreased last week with six new deals announced. Acacia Communications and Cisco Systems announced an amendment to their merger agreement. Google completes the acquisition of Fitbit. For further details see: Merger Arbitrage Mondays - Fitbit Closes And A...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) announced today that the acquisition of shares of common stock of Eidos not held by Br...
2020 was a year of immense adversity and contrast, as stocks bounced back sharply from a pandemic-induced bear market. Biotechs play a pivotal role in managing down the pandemic as vaccine production ramps higher. January to provide further insights on multiple additional vaccine tria...
Merger activity increased significantly last week with eight new deals announced. The acquisition of Alaska Communications Systems Group by ATN International. The acquisition of FLIR Systems by Teledyne Technologies Incorporated. For further details see: Merger...
It's only been a couple of years since BridgeBio Pharma (NASDAQ: BBIO) made its stock market debut, and the company already has two new drug applications under review by the Food and Drug Administration. This biotech start-up foundry hasn't had any trouble attracting institutional c...
A substantive review of its U.S. biopharmaceutical coverage finds BofA looking to a "return to normal" for the sector in a year expected to be dominated by news about a number of COVID-19 vaccines. Biopharma had a strong year overall - with the Biotech side outperforming the broader market (N...
Have you been looking for stocks that can double your money or better this year? Smart investors know the biotech industry's full of clinical-stage companies that can explode in value overnight in response to positive clinical trial results or Food and Drug Administration approvals. E...
Merger activity decreased last week with one new deal announced. The acquisition of Red Lion Hotels (RLH) by Sonesta International Hotels. Perella Weinberg Partners and FinTech Acquisition Corp. IV enter into a definitive business combination agreement. For further details s...
PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) recommends that BridgeBio stockholders and Eidos Therapeutics, Inc. (Nasdaq: EIDX) stockholder...
News, Short Squeeze, Breakout and More Instantly...
PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, announced that Thomas Trimarchi, Ph.D., has been appointed President and...
2024-07-09 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-20 00:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...